I can't believe the sp is still under 20p..........17 Jan 2024 15:57
Really.
The molecular analysis Co's THROUGHOUT THE WORLD should be talking to Angle about the benefits of adding the molecular analysis of circulating tumour cells to their existing molecular analysis offerings.
It's a NO BRAINER (at the risks of insults on here, LOL!!!). Any of these Companies not checking this out need their CEO's replacing with someone who has a clue. LOL!
All IMHO,